Burning Rock Biotech Limited (BNR)

EBITDA Growth

34.10%

TTM · Period ending:

BNR logo

BNR EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported34.10%
BNR TTM EBITDA YoY % (-265.19% → 34.10%)
High-resolution chart · PNG

BNR ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Burning Rock Biotech Limited EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
34.1019%
79.6282%
88.8445%
82.6369%
85.0739%
62.8233%
47.4022%
56.0324%
40.8401%
48.2907%
45.8146%
28.2671%
16.5447%
-7.7213%
-31.3563%
-42.9685%
-43.3399%
-61.6866%
-90.6045%
-103.6151%
-168.3307%
-176.5443%
-167.8737%
-265.19%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.